Treatment for herpes virus

• US 4,285,934 A
• Filed: 06/23/1980
• Issued: 08/25/1981
• Est. Priority Date: 07/13/1979
• Status: Expired due to Term

• Current Assignee: Zila Pharmaceuticals Incorporated (TOLMAR Holding, Inc.)
• Original Assignee: Zila Pharmaceuticals Incorporated (TOLMAR Holding, Inc.)
• Inventors: Tinnell, James E.
• Primary Examiner(s): Goldberg, Jerome D.
• Application Number:
  US06/162,252
• Time in Patent Office: 428 Days
• Field of Search: 424/148, 424/195, 424/230
• US Class Current: 424/659
• CPC Class Codes: A61K 31/045 Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
• CPC Class Codes: A61K 31/60 Salicylic acid; Derivatives thereof
• CPC Class Codes: A61K 31/70 Carbohydrates; Sugars; Derivatives thereof sorbitol A61K31/047
• CPC Class Codes: A61K 33/22 Boron compounds
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61P 31/12 Antivirals

Abstract

A treatment for herpes virus infections comprises topical application of a suspension of boric acid, tannic acid, and salicylic acid, preferably in an ethanol solvent/carrier. Typically, a solution would have about 15% wt each of tannic and boric acids to 3% wt salicylic acid. After treatment, herpes lesions disappear within 4-5 days.

Claims

1. A composition for treating herpes virus lesions comprising boric acid, tannic acid and salicylic acid in the weight ratio of about 7:

7;

3.

2. A method for treatment of herpes virus lesions in a human host comprising topically applying to the lesions an effective amount of a composition comprising boric acid, tannic acid and salicylic acid in the weight ratio of about 7:

7;

3.